Novavax is offering parents up to $3,000 to enroll their children in the vaccine maker’s Phase 2/3 COVID-19 vaccine trial for infants and children ages 6 months to 11 years. The offer also includes a stuffed animal for each child.
The “Hummingbird trial” is testing two primary shots and a booster shot of Novavax’s adjuvanted recombinant spike protein nanoparticle vaccine in children. The study, which began in 2022, is enrolling 3,600 children.
The study, which began in the U.S., is expected to run through 2025 and will be conducted in the U.S. and other countries.
The children will receive three injections and visit the clinic eight times. Parents will participate in three phone calls and keep an e-diary of the vaccine’s effects on their child. Some children will receive two additional injections, for a total of five shots.
MORE ON THIS ⬇️
https://childrenshealthdefense.org/defender/novavax-covid-vaccine-trial-infants-children/?utm_source=telegram&utm_medium=social&utm_campaign=defender&utm_id=20240829
The “Hummingbird trial” is testing two primary shots and a booster shot of Novavax’s adjuvanted recombinant spike protein nanoparticle vaccine in children. The study, which began in 2022, is enrolling 3,600 children.
The study, which began in the U.S., is expected to run through 2025 and will be conducted in the U.S. and other countries.
The children will receive three injections and visit the clinic eight times. Parents will participate in three phone calls and keep an e-diary of the vaccine’s effects on their child. Some children will receive two additional injections, for a total of five shots.
https://childrenshealthdefense.org/defender/novavax-covid-vaccine-trial-infants-children/?utm_source=telegram&utm_medium=social&utm_campaign=defender&utm_id=20240829